NSHPT is a rare life-threatening disease characterized by marked hypercalcemia, diffuse parathyroid hyperplasia and skeletal demineralization, due to the biallelic inactivation (homozygous or compound heterozygous mutations) of the CaSR gene. Here, CASR is linked to neonatal severe primary hyperparathyroidism.